At Verastem Oncology, we're advancing innovation and addressing the urgent needs of patients living with cancers driven by RAS/MAPK pathway mutations, a key driver of tumor growth and treatment resistance. The FDA approval of AVMAPKI FAKZYNJA CO-PACK delivered the first therapy specifically for women living with recurrent KRAS-mutated low-grade serous ovarian cancer, a rare cancer with significant unmet need. We’ve successfully launched this innovative combination therapy in the U.S. and are exploring regulatory pathways for Europe and Japan. We are continuing to advance our pipeline of drugs that we believe will help block cancer cell survival, inhibit tumor growth, and overcome treatment resistance. With clinical trials underway, we have an exciting opportunity to shape the future of cancer care and make a meaningful impact in the lives of patients. Summary: The core mission of the Verastem Safety & Pharmacovigilance group is to ensure patient safety for all patient’s receiving Verastem manufactured products. This is done by ensuring that the safety profile of Verastem products remains accurate and up to date throughout the product life cycle of development and through the following core activities: Relevant safety information including reports of side effects is collected and analyzed. Possible safety signals are carefully validated and characterized. Strategies are implemented to minimize risks and to ensure that products are used in a way that maximizes benefits and minimizes risks. Key among these is to ensure that accurate and up-to-date information on the safety profile of Verastem products is available to patients and prescribers in a timely manner. Communication with patients, providers, regulatory agencies, and other concerned bodies is essential to this effort. This includes developing and updating the investigator brochure, and protocols as well as any adjunct information for patients and health professionals. This information must be kept current throughout the life cycle of each product. Reporting to the Vice President, PV Operations and Compliance, Senior Pharmacovigilance Operations Specialist will be responsible for the managing drug safety case management vendor, safety submission execution and compliance, and cross functional collaboration to support risk management and pharmacovigilance activities for the Global Patient Safety department.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level